Prick puncture skin tests and serum specific IgE as predictors of nasal challenge response to Dermatophagoides pteronyssinus in older adults

Annals of Allergy, Asthma and Immunology

Volumn 101, Issue 1, 2008, Pages 12-17

  King, Monroe J ^a   Tamulis, Tomas ^b   Lockey, Richard F ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E;

ADULT; AGED; ALLERGIC REACTION; ALLERGIC RHINITIS; ALLERGY TEST; ARTICLE; CLINICAL ARTICLE; DERMATOPHAGOIDES PTERONYSSINUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; NOSE PROVOCATION TEST; PREDICTION; PRICK TEST; PRIORITY JOURNAL; PUNCTURE;

EID: 47349124067     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60828-9     Document Type: Article

References (23)

1. Sahin-Yilmaz AA, Corey JP. Rhinitis in the elderly. Curr Allergy Asthma Rep. 2006;6:125-131.
2. Riechelmann H, Mewes T, Weschta M, Gropper G. Nasal allergen provocation with Dermatophagoides pteronyssinus in with chronic rhinitis referred to a rhinologic surgical center. Ann Allergy Asthma Immunol. 2002;88:624-631.
3. Simola M, Holopainene E, Malmberg H. Changes in skin and nasal sensitivity to allergens and the course of rhinitis: a long-term follow-up study. Ann Allergy Asthma Immunol. 1999;82:152-156.
4. Paganelli R, Ansotegui IJ, Sastre J, et al. Specific IgE antibodies in the diagnosis of atopic disease: clinical evaluation of a new in vitro test system, UniCAP, in six European allergy clinics. Allergy. 1998;53:763-768.
5. Youlten LJ. Nasal airway patency measurement in the assessment of rhinitis therapy. Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M. 1983;78:111-113.
6. Gendo K, Larson EB. Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis. Ann Intern Med. 2004;140:278-289.
7. Jaeschke R, Guyatt GH, Sackett DL; The Evidence-Based Medicine Working Group. Users' guides to the medical literature, III: how to use an article about a diagnostic test: B, what are the results and will they help me in caring for my patients? JAMA. 1994;271:703-707.
8. Bousquet and the ARIA Workshop Group. Allergic rhinitis and its impact on asthma (ARIA) in collaboration with the World Health Organization (WHO). J Allergy Clin Immunol. 2001;108:S147-S336.
9. Olderenbeuving NB, KleinJan A, Mulder PG, et al. Evaluation of an intranasal house dust mite provocation model as a tool in clinical research. Allergy. 2005;60:751-759.
10. Hellgren J, Jarlstedt J, Dimberg L, Toren K, Karlsson G. A study of some current methods for assessment of nasal histamine reactivity. Clin Otolaryngol Allied Sci. 1997;22:536-541.
11. Fokkens WJ, Vinke JG, KleinJan A. Local IgE production in the nasal mucosa: a review. Am J Rhinol. 2000;14:299-302.
12. Yoshida T, Usui A, Kusumi T, et al. A quantitative analysis of cedar pollen-specific immunoglobulins in nasal lavage supported the local production of specific IgE, not of specific IgG. Microbiol Immunol. 2005;49:529-534.
13. KleinJan A, Vinke JG, Severijnen LW, Fokkens WJ. Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur Respir J. 2000;15:491-497.
14. Takhar P, Smurthwaite L, Coker HA, et al. Allergen drives class switching to IgE in the nasal mucosa in allergic rhinitis. J Immunol. 2005;174:5024-5032.
15. Huggins KG, Brostoff J. Local production of specific IgE antibodies in allergic-rhinitis patients with negative skin tests. Lancet. 1975;2:148-150.
16. Carney AS, Powe DG, Huskisson RS, Jones NS. Atypical nasal challenges in patients with idiopathic rhinitis: More evidence for the existence of allergy in the absence of atopy? Clin Exp Allergy. 2002;32:1436-1440.
17. Rondón C, Romero JJ, Lopez S et al. Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis. J Allergy Clin Immunol. 2007;119:899-905.
18. Lin H, Boesel KM, Griffith DT, Prussin C et al. Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils. J Allergy Clin Immunol. 2004;113:297-302.
19. Beck LA, Barcotte GV, MacGlashan D Jr, Togias A, Saini S. Omalizumab-induced reductions in mast cell FcεRI expression and function. J Allergy Clin Immunol. 2004;114:527-530.
20. Ong YE, Menzies-Gow A, Barkans J, et al. Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge. J Allergy Clin Immunol. 2005;116:558-564.
21. Getchell ML, Chen Y, Ding X, Sparks DL, Getchell TV. Immunohistochemical localization of a cytochrome P-450 isozyme in human nasal mucosa: Age-related trends. Ann Otol Rhinol Laryngol. 1993;102:368-374.
22. Edelstein DR. Aging of the normal nose in adults. Laryngoscope. 1996;106(suppl 81):1-25.
23. Schrödter S, Biermann E, Halata Z. Histological evaluation of age-related changes in human respiratory mucosa of the middle turbinate. Anat Embryol. 2003;207:19-27.